Labiana Health, S.A. (BME:LAB)

Spain flag Spain · Delayed Price · Currency is EUR
4.280
-0.220 (-4.89%)
At close: Feb 5, 2026
48.61%
Market Cap29.94M +47.7%
Revenue (ttm)71.67M +8.4%
Net Income904.36K
EPS0.13
Shares Out7.00M
PE Ratio33.11
Forward PE11.87
Dividendn/a
Ex-Dividend Daten/a
Volume4,039
Average Volume1,195
Open4.500
Previous Close4.500
Day's Range4.280 - 4.500
52-Week Range2.640 - 4.900
Beta0.15
RSI47.72
Earnings DateApr 22, 2026

About Labiana Health

Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized dosage forms, bacterial vaccines and biological formats; and Fosfomycin trometamol under the Fosfomicina Labiana brand name. In addition, the company offers contrac... [Read more]

Sector Healthcare
Founded 1958
Employees 394
Stock Exchange Madrid Stock Exchange
Ticker Symbol LAB
Full Company Profile

Financial Performance

Financial Statements